Carsten Niemann

Clinical Associate Professor

Department of Clinical Medicine
Blegdamsvej 9, 2100 København Ø
- carsten.utoft.niemann@regionh.dk
- https://ikm.ku.dk/
Phone: +4535457830

Member of:

Internal Medicine: Haematology

All
Research

Publication year:

All

61 - 70 out of 95Page size: 10

Sort by: Publication date

2021
Published
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study
da Cunha-Bang, C., Rostgaard, K., Andersen, M. A., Rotbain, E. C., Grønbæk, Kirsten, Frederiksen, H., Niemann, Carsten & Hjalgrim, Henrik, 2021, In: British Journal of Haematology. 193, 2, p. 339-345
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Targeting the tumor microenvironment in chronic lymphocytic leukemia
Svanberg, R., Janum, S., Patten, P. E. M., Ramsay, A. G. & Niemann, Carsten, 2021, In: Haematologica. 106, 9, p. 2312-2324
Research output: Contribution to journal › Review › Research › peer-review
Published
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, Carsten, Levin, M., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 2021, In: Blood. 137, 8, p. 1117-1120
Research output: Contribution to journal › Letter › Research › peer-review
2020
Published
The Number of Signaling Pathways Altered by Driver Mutations in Chronic Lymphocytic Leukemia Impacts Disease Outcome
Brieghel, C., da Cunha-Bang, C., Yde, C. W., Schmidt, A. Y., Kinalis, S., Nadeu, F., Andersen, M. A., Jacobsen, L. O., Andersen, M. K., Pedersen, L. B., Delgado, J., Baumann, T., Mattsson, M., Mansouri, L., Rosenquist, R., Campo, E., Nielsen, Finn Cilius & Niemann, Carsten, 15 Mar 2020, In: Clinical Cancer Research. 26, 6, p. 1507-1515 9 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
COVID-19 among fit patients with CLL treated with venetoclax-based combinations
Fürstenau, M., Langerbeins, P., De Silva, N., Fink, A. M., Robrecht, S., von Tresckow, J., Simon, F., Hohloch, K., Droogendijk, J., van der Klift, M., van der Spek, E., Illmer, T., Schöttker, B., Fischer, K., Wendtner, C. M., Tausch, E., Stilgenbauer, S., Niemann, C. U., Gregor, M., Kater, A. P. & 2 others, Hallek, M. & Eichhorst, B., 2020, In: Leukemia. 34, 8, p. 2225-2229 5 p.
Research output: Contribution to journal › Letter › Research › peer-review
Published
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Scarfò, L., Chatzikonstantinou, T., Rigolin, G. M., Quaresmini, G., Motta, M., Vitale, C., Garcia-Marco, J. A., Hernández-Rivas, J. Á., Mirás, F., Baile, M., Marquet, J., Niemann, C. U., Reda, G., Munir, T., Gimeno, E., Marchetti, M., Quaglia, F. M., Varettoni, M., Delgado, J., Iyengar, S. & 62 others, Janssens, A., Marasca, R., Ferrari, A., Cuéllar-García, C., Itchaki, G., Špaček, M., De Paoli, L., Laurenti, L., Levin, M. D., Lista, E., Mauro, F. R., Šimkovič, M., Van Der Spek, E., Vandenberghe, E., Trentin, L., Wasik-Szczepanek, E., Ruchlemer, R., Bron, D., De Paolis, M. R., Del Poeta, G., Farina, L., Foglietta, M., Gentile, M., Herishanu, Y., Herold, T., Jaksic, O., Kater, A. P., Kersting, S., Malerba, L., Orsucci, L., Popov, V. M., Sportoletti, P., Yassin, M., Pocali, B., Barna, G., Chiarenza, A., dos Santos, G., Nikitin, E., Andres, M., Dimou, M., Doubek, M., Enrico, A., Hakobyan, Y., Kalashnikova, O., Ortiz Pareja, M., Papaioannou, M., Rossi, D., Shah, N., Shrestha, A., Stanca, O., Stavroyianni, N., Strugov, V., Tam, C., Zdrenghea, M., Coscia, M., Stamatopoulos, K., Rossi, G., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A. & Ghia, P., 2020, In: Leukemia. 34, 9, p. 2354-2363 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib
Svanberg, R., Ostrowski, Sisse Rye, Nasserinejad, K., Kersting, S., Dobber, J. A., Mattson, M., Tran, H. T. T., Levin, M., Mous, R., Kater, A. P. & Niemann, Carsten, 2020, In: Leukemia and Lymphoma. 61, 14, p. 3422-3431 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma
Andersen, M. A., Valentin, R., Sjö, Lene Dissing, Borgwardt, L., Schmiegelow, Kjeld, Andersen, M. K., Marvig, R. L., Yde, C. W. & Niemann, Carsten, 2020, In: Acta Oncologica. 59, 12, p. 1547-1551
Research output: Contribution to journal › Comment/debate › Research › peer-review
Published
Cost-effectiveness targeting CLL
Niemann, Carsten, 2020, In: Blood. 136, 17, p. 1896-1898
Research output: Contribution to journal › Editorial › Research › peer-review
Published
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: A danish nationwide population-based study
Rotbain, E. C., Frederiksen, H., Hjalgrim, Henrik, Rostgaard, K., Egholm, G. J., Zahedi, B., Poulsen, C. B., Enggard, L., Da Cunha-Bang, C. & Niemann, Carsten, 2020, In: Haematologica. 105, 6, p. 1621-1629 9 p.
Research output: Contribution to journal › Journal article › Research › peer-review